Empowerment program for managing Type 2 Diabetes
Validation of an Integrated Attention Model for Patients With Type 2 Diabetes
NA · Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran · NCT02836808
This study is testing an empowerment program that helps people with Type 2 Diabetes manage their condition better through education and support over two years.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 1200 (estimated) |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Sponsor | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran (other) |
| Locations | 1 site (Mexico City, Mexico City) |
| Trial ID | NCT02836808 on ClinicalTrials.gov |
What this trial studies
This intervention focuses on providing education and empowerment techniques to patients with Type 2 Diabetes through a structured program at the Center for Comprehensive Care of Patients with Diabetes (CAIPaDi). The program includes four monthly visits followed by ongoing support via internet or cell phone technology. It aims to improve self-care activities and achieve international treatment standards over a two-year period. The study will measure the program's impact on various health parameters, including HbA1c levels and blood pressure.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 to 70 with a diagnosis of Type 2 Diabetes for less than five years and no chronic complications.
Not a fit: Patients with advanced diabetes complications or other serious health conditions may not benefit from this program.
Why it matters
Potential benefit: If successful, this program could significantly improve the management and outcomes of patients with Type 2 Diabetes.
How similar studies have performed: Other studies have shown positive outcomes with similar empowerment and self-management approaches for chronic diseases, indicating potential for success in this intervention.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * being over 18 and under 70 years old * having diagnosis of type 2 diabetes in the five previous years, * having family support * free of disabling diabetes complications Exclusion Criteria: * advanced complications of diabetes, such as ischemic heart disease, heart failure NYHA III-IV, KDOQI ≥3 renal failure, amputations, cerebral vascular disease, gastroparesis and muscular atrophy . * type 1 diabetes mellitus, gestational diabetes or some variant of diabetes related to genetic syndromes, hyperlabile diabetes * co-morbidities that limit their life expectancy such as malignant tumors * advanced cognitive impairment or serious psychiatric disorders * smoking, alcoholism or illegal drug dependence * conditions that require surgical treatment in the short run or which prevent moderated activity.
Where this trial is running
Mexico City, Mexico City
- Instituto Nacional de Ciencias Medicas y Nutricion — Mexico City, Mexico City, Mexico (RECRUITING)
Study contacts
- Principal investigator: Sergio C Hernández, MD — National Institute of Medical Sciences and Nutrition Salvador Zubirán
- Study coordinator: Sergio Hernández, MD
- Email: sergiohdzj@hotmail.com
- Phone: 57870900
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Type 2 Diabetes, Multidisciplinary interventions, Long term control, Empowerment